Will Stone

Metric and other researchers acknowledge cannabis itself is not harm-free and concerns about the drug also need to be weighed, and that more research needs to be done before making any kind of recommendations.

Will Stone, NPR News.

The tales from NPR's Bullstone.

States in the middle of the country, especially Minnesota, have seen a big spike.

As wild birds migrate, they can seed outbreaks on farms.

The virus has not shown up much in dairy cattle in recent months, though scientists say that may be due to lack of testing.

And all of this presents a risk to farm workers.

Dr. Nirav Shah helped lead the bird flu response under President Biden.

Shaw says cutbacks in the federal workforce and the government shutdown have put the country in a precarious situation and make it more likely human cases could go undetected.

Meanwhile, farm workers, who are often undocumented, are reluctant to get tested because of the administration's immigration enforcement.

Will Stone, NPR News.

The findings come from a pair of major clinical trials on patients with low back pain, the leading cause of disability.

The first showed that a blend of cannabis oil containing the psychoactive compound THC outperformed a placebo.

The other compared it to opioids and showed cannabis had fewer GI side effects and provided better relief.

The company tells NPR it's being required to repeat the studies in the U.S.

before seeking approval from regulators here.

Richard Price, a spine surgeon at UC Davis, says many of his patients ask about using cannabis.

Because cannabis is a Schedule I drug, running large research trials comes with many obstacles, meaning it will likely be years before that additional research gets completed.

Will Stone, NPR News.

The basic idea is to force accreditation to be focused on the merit and the actual results that these universities are providing, as opposed to how woke these universities have gotten.